Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
19 February 2015 |
Main ID: |
NCT02240953 |
Date of registration:
|
12/09/2014 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Anticoagulation Regiments in Patients With Prosthetic Heart Valve Thrombosis
|
Scientific title:
|
Comparison of Different Anticoagulation Regiments in Patients With Prosthetic Heart Valve Non-ObstructiveThrombosis |
Date of first enrolment:
|
January 2009 |
Target sample size:
|
180 |
Recruitment status: |
Recruiting |
URL:
|
http://clinicaltrials.gov/show/NCT02240953 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Turkey
| | | | | | | |
Contacts
|
Name:
|
Mehmet Özkan, Prof |
Address:
|
|
Telephone:
|
905322551512 |
Email:
|
memoozkan1@gmail.com |
Affiliation:
|
|
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Patients with prosthetic heart valve thrombosis
Exclusion Criteria:
Age minimum:
18 Years
Age maximum:
80 Years
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Thrombosis
|
Intervention(s)
|
Drug: Observational Warfarin
|
Drug: Warfarin + ASA 300 mg + PPI
|
Drug: Warfarin + ASA 100 mg + PPI
|
Drug: Warfarin
|
Primary Outcome(s)
|
Same thrombus size
[Time Frame: 6 months]
|
Decreased thrombus size
[Time Frame: 6 months]
|
Complications
[Time Frame: 6 months]
|
Increased thrombus size
[Time Frame: 6 months]
|
Secondary ID(s)
|
KOSUYOLU2
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|